Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04579757
Recruitment Status : Recruiting
First Posted : October 8, 2020
Last Update Posted : September 27, 2021
Sponsor:
Collaborator:
BeiGene
Information provided by (Responsible Party):
Hutchison Medipharma Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 27, 2023
Estimated Study Completion Date : April 30, 2023